Profusa Advances G3 Vision Labs Acquisition with $10.7M Debt-to-Equity Exchanges and $650K Borrowing

summarizeSummary

Profusa reported progress on its G3 Vision Labs acquisition, including $10.7 million in debt-to-equity exchanges and a $650,000 borrowing, while Q2 losses widened to $8.8 million.

check_boxKey Events · M&A and Partnerships · PFSA

• Debt-to-Equity Exchanges

  Debt and liabilities holders executed $10.7 million of Series A Convertible Exchange Agreements, with $4.57 million converted into 4,271.298 shares of Series A Convertible Preferred Stock.

• Working Capital Borrowing

  Profusa borrowed $650,000 under its current note agreement to fund near-term working capital needs.

• Equity Swing

  Stockholders' equity is expected to be $28.4 million as of July 31, 2026, compared to a $(27.1) million deficit at June 30, 2026, driven by the option agreement and reverse split.

• G3 Audit Timeline

  G3 auditors expect to issue audited financial statements for most entities by end of August and the entire business by mid-September.

auto_awesomeAnalysis · PFSA · Industrial Applications And Services

Profusa is making concrete progress toward closing its option to acquire G3 Vision Labs, a commercial-stage diagnostics company. Debt and liability holders have executed $10.7 million in Series A Convertible Exchange Agreements, with $4.57 million already converted into preferred stock. The company also borrowed $650,000 to fund near-term working capital. These moves address the severe cash crunch and going concern doubts highlighted in yesterday's 10-Q, but they also introduce significant dilution risk for existing shareholders. The expected swing from a $(27.1) million stockholders' deficit to $28.4 million equity by July 31, 2026 reflects the impact of the option agreement and reverse split, but the company remains highly leveraged with $28.2 million in liabilities against only $1.0 million in total assets.